Lung Tumor

2

Review clinical trials related to Lung Tumor. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

The MOMENTUM Study: The Multiple Outcome Evaluation of Radiation Therapy Using the MR-Linac Study

The Multi-OutcoMe EvaluatioN of radiation Therapy Using the Unity MR-Linac Study (MOMENTUM) is a multi-institutional, international registry facilitating evidenced based implementation of the Unity MR-Linac technology and further technical development of the MR-Linac system with the ultimate purpose to improve patients' survival, local, and regional tumor control and quality of life.

Participants needed: 8,000
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: UMC UtrechtUpdated: Mar 5, 2026Locations: 18Duration: 2 Years
Eligibility criteria

Patient is to undergo or has completed imaging or treatment procedures on an MR-... [+2]

MRI exclusion criteria, including [+1]

Status: Recruiting

RealMove (Lung): Assessing Tumour Motion With Dynamic MRI

The study aims to develop an improved method to tailor the geometric safety margin when treating with stereotactic body radiotherapy (SBRT), to avoid tumour cells being missed during irradiation and to limit the exposure of normal tissues as much as possible. Dynamic magnetic resonance imaging (MRI) is assumed to represent the tumour motion during the respiratory cycle more realistically, compared to 4-dimensional computed tomography (4D CT), thanks to its high temporal resolution and the possibility to image the motion over a longer period of time. Patients receiving SBRT for a pulmonary target located below the level of the carina are included in the study, and the hypothesis will be tested through a comparison of the tumour amplitude measured with each modality. Furthermore, the predictive value of the image series acquired at treatment planning, for the motion patterns observed at each treatment fraction, will be evaluated through repeated 4D CBCT acquisitions.

Participants needed: 150
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: Region StockholmUpdated: Sep 2, 2025Locations: 1
Eligibility criteria

Accepted for SBRT treatment of one or more caudally situated lung targets (NSCLC... [+3]

Pregnancy or breastfeeding, or planned pregnancy or breastfeeding, during treatm... [+2]